Ibrexafungerp Citrate

Ibrexafungerp Citrate is a triterpenoid antifungal API used to treat fungal infections, particularly vulvovaginal candidiasis. It works by inhibiting fungal glucan synthase, disrupting the fungal cell wall. It is a small-molecule chemical API, not a peptide or oligonucleotide. Its therapeutic use is listed as antifungals. Other names for this substance include brexafemme and SCY-078 citrate. Its PubChem CID is 137552087.

CAS No 1965291-08-0
Molecular Formula C50H75N5O11
Molecular Weight 922.2 g/mol
Synonyms (1R,5S,6R,7R,10R,11R,14R,15S,20R,21R)-21-[(2R)-2-amino-2,3,3-trimethylbutoxy]-5,7,10,15-tetramethyl-7-[(2R)-3-methylbutan-2-yl]-20-(5-pyridin-4-yl-1,2,4-triazol-1-yl)-17-oxapentacyclo[13.3.3.01,14.02,11.05,10]henicos-2-ene-6-carboxylic acid;2-hydroxypropane-1,2,3-tricarboxylic acid

Frequently Asked Questions